 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
SUPREME COURT TAKES NO ACTION ON HEARING ROUNDUP LAWSUIT
Jun. 15, 2022
by Lawrence Hurley, Reuters
WASHINGTON - The U.S. Supreme Court on Monday took no action on Bayer AG's (BAYGn.DE) bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the German company seeks to avoid potentially billions of dollars in damages.
The case was not mentioned on a list issued by the court on Monday as it decided on whether to hear pending appeals, raising at least the possibility that the justices are considering hearing it. Bayer has asked the justices to take up its appeal of a lower court decision that upheld $25 million in damages awarded to California resident Edwin Hardeman, a Roundup user who blamed his cancer on the pharmaceutical and chemical giant's glyphosate-based weedkillers.
The Supreme Court's decision on whether to take up the appeal is being closely watched as Bayer maneuvers to limit its legal liability in thousands of cases.
U.S. President Joe Biden's administration in May urged the court not to hear the Bayer appeal, reversing the government's position previously taken under former President Donald Trump.
Bayer has lost three trials in which Roundup users have been awarded tens of millions of dollars in each. Bayer has pinned hopes for relief on the conservative-majority Supreme Court, which has a reputation for being pro-business. Bayer has won three trials, including one last week.
To read the entire report click here.
|
|
|
|
|
